Psy32 Cost-Effect Analysis of the Use of Posaconazole for Prophylaxis of Invasive Mycoses Compared to Fluconazole and Itraconazole in Patients With Pronounced Neutropenia

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Psy32 Cost-Effect Analysis of the Use of Posaconazole for Prophylaxis of Invasive Mycoses Compared to Fluconazole and Itraconazole in Patients With Pronounced Neutropenia

Cited by 1 publication

References 0 publications

An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States

An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States

Contact Info

Product

Resources

About